The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

Q1 2025 Earnings Call Transcript February 6, 2025 Embecta Corp. beats earnings expectations. Reported EPS is $0.65, ...

The US FDA warns users of smartphone-linked diabetes devices like CGMs and insulin pumps of potential health risks due to ...

These days, many devices are programmed through apps on patients’ phones. But the FDA warns that certain phone settings, such ...

There’s an ongoing push to improve health care affordability and reduce out-of-pocket costs, especially for prescription ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Adjusted EBITDA margin increased to 37.2% from 25.2% in Q4 2024, driven by cost reductions and operational improvements. Management's tone shifted positively, highlighting stronger-than-expected ...

Managing diabetes is even harder when temperatures and humidity are rising. Find out how extreme heat can negatively affect ...

Diabetes device expert Steph Habif said her family's experiment with CGMs shows a big opportunity for wearables: intermittent ...

Collin, from Sioux Falls, South Dakota, had grown up a Chiefs fan alongside older brother, Jayce. After being diagnosed with Type 1 diabetes at age 3, however, Collin also gravitated to having a ...

Modular Medical develops patented insulin delivery technologies, aiming to improve access to glycemic control. Its founder, ...